Procaps Gr (NASDAQ:PROC) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Procaps Gr (PROC) operate in?

Procaps Gr is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Procaps Gr Stock (NASDAQ: PROC) stock price, news, charts, stock research, profile.

Open	$2.45
Close	$2.40
Volume / Avg.	12.03K / 5.05K
Day Range	2.40 - 2.47
52 Wk Range	1.95 - 4.95
Market Cap	$347.50M
P/E Ratio	4.71
Dividend Yield	-
Exchange	NASDAQ
RSI	47
Short Interest	0.02%
Days to Cover	1.64

Recent News

Ecolab Posts Strong Results, Joins Masonite International, Impinj And Other Big Stocks Moving Higher On Tuesday

U.S. stocks were lower, with the Dow Jones index dipping more than 500 points on Tuesday.

Avi Kapoor

Pharma Company Procaps Beats On Q3 But Lowers FY23 Guidance: Here's Why

Procaps Group SA (NASDAQ: PROC) reported Q3 FY23 revenue of $118.41 million, beating the consensus of $110.4 million and rose 7% Y/Y (+2% Y/Y in constant currency), led by the performance of RX and OTC portfolios.

Lekha Gupta

Coherus BioSciences, Ascent Industries And 3 Stocks To Watch Heading Into Wednesday

With U.S. stock futures trading lower this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating and Forecast

3.0

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

About Procaps Group S.A

Sector

Health Care

Industry

Pharmaceuticals

Procaps Group SA is a developer of pharmaceutical and nutraceutical solutions, medicines, and hospit...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Procaps Gr (PROC) stock?

You can purchase shares of Procaps Gr (NASDAQ:PROC) through any online brokerage.

View our list of the best stock brokerages

Who are Procaps Gr (PROC) competitors?

Other companies in Procaps Gr’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Theravance Biopharma (NASDAQ:TBPH), Zevra Therapeutics (NASDAQ:ZVRA), Xeris Biopharma Holdings (NASDAQ:XERS) and Aquestive Therapeutics (NASDAQ:AQST).

What is the target price for Procaps Gr (PROC) stock?

There is no analysis for Procaps Gr.

What is the forecast for Procaps Gr (PROC) stock?

Procaps Gr has a consensus price target of $4.50.

Current stock price for Procaps Gr (PROC)?

The stock price for Procaps Gr (NASDAQ: PROC) is $3.08 last updated March 15, 2024 at 4:38 PM EDT.

Does Procaps Gr (PROC) pay a dividend?

There are no upcoming dividends for Procaps Gr.

When is Procaps Gr (NASDAQ:PROC) reporting earnings?

Procaps Gr’s Q2 earnings are confirmed for Tuesday, September 3, 2024.

Is Procaps Gr (PROC) going to split?

There is no upcoming split for Procaps Gr.

What sector and industry does Procaps Gr (PROC) operate in?

Procaps Gr is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comments

Procaps Gr

Procaps Gr (PROC) Forecast